Clinical trial
LIraglutide and Beta-cell RepAir (LIBRA) Study
NCT01270789
Study timeline
Study start (unknown)2011-01-01Date precision: month
Registry last updated2014-09-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
placeboDRUG
Sponsors & collaborators
Mount Sinai Hospital, Canadalead sponsor
Novo Nordisk A/Scollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01270789 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.